CAPTRUST Financial Advisors
PBE icon

CAPTRUST Financial Advisors’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

CAPTRUST Financial Advisors’s Portfolio PBE Stock Details PBE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,107
Closed -$217K – 2372
2024
Q3 		$217K Sell
3,107
-1,227
-28% -$84.9K ﹤0.01% 2082
2024
Q2 		$281K Buy
4,334
+74
+2% +$4.69K ﹤0.01% 1846
2024
Q1 		$276K Buy
4,260
+1,138
+36% +$74.1K ﹤0.01% 1821
2023
Q4 		$206K Sell
3,122
-1,027
-25% -$59.7K ﹤0.01% 2384
2023
Q3 		$237K Sell
4,149
-59
-1% -$3.6K ﹤0.01% 2175
2023
Q2 		$258K Buy
+4,208
New +$263K ﹤0.01% 2085
2022
Q3 		– Sell
-1,054
Closed -$61K – 3435
2022
Q2 		$61K Hold
1,054
– – ﹤0.01% 2591
2022
Q1 		$65K Hold
1,054
– – ﹤0.01% 2600
2021
Q4 		$75K Hold
1,054
– – ﹤0.01% 2367
2021
Q3 		$79K Hold
1,054
– – ﹤0.01% 2260
2021
Q2 		$82K Hold
1,054
– – ﹤0.01% 2178
2021
Q1 		$78K Hold
1,054
– – ﹤0.01% 2134
2020
Q4 		$74K Sell
1,054
-107
-9% -$6.77K ﹤0.01% 1656
2020
Q3 		$67K Hold
1,161
– – ﹤0.01% 1529
2020
Q2 		$68K Buy
+1,161
New +$63.3K ﹤0.01% 1500
2019
Q4 		– Sell
-250
Closed -$12K – 1559
2019
Q3 		$12K Hold
250
– – ﹤0.01% 1447
2019
Q2 		$13K Hold
250
– – ﹤0.01% 1430
2019
Q1 		$14K Hold
250
– – ﹤0.01% 1296
2018
Q4 		$12K Hold
250
– – ﹤0.01% 1177
2018
Q3 		$15K Hold
250
– – ﹤0.01% 1108
2018
Q2 		$14K Hold
250
– – ﹤0.01% 1072
2018
Q1 		$12K Hold
250
– – ﹤0.01% 986
2017
Q4 		$12K Hold
250
– – ﹤0.01% 948
2017
Q3 		$12K Buy
+250
New +$11.9K ﹤0.01% 421

Other funds holding PBE

GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
YIA
YHB Investment Advisors West Hartford, Connecticut $1.56B AUM 27.39% 1-Year Est. Return

CAPTRUST Financial Advisors's PBE Position: Q4 2024 in Review

CAPTRUST Financial Advisors sold out of Invesco Biotechnology & Genome ETF (PBE) in Q4 2024, closing a stake of 3,107 shares — an estimated $217K sold.

CAPTRUST Financial Advisors first reported a position in PBE in Q3 2017 and held it in 24 quarters. The position peaked at $281K in Q2 2024. 96 funds tracked by Wall St. Rank hold PBE as of Q4 2024.

  • CAPTRUST Financial Advisors reported no remaining Invesco Biotechnology & Genome ETF position as of Q4 2024 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 3,107 Invesco Biotechnology & Genome ETF shares in Q4 2024, an estimated $217K.
  • CAPTRUST Financial Advisors first reported a position in Invesco Biotechnology & Genome ETF in Q3 2017 and held it in 24 quarters.
  • CAPTRUST Financial Advisors's Invesco Biotechnology & Genome ETF position peaked at $281K in Q2 2024.
  • 96 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q4 2024.

Based on CAPTRUST Financial Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.